Clinical Trial Update: Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase I trial evaluating triciribine phosphate monohydrate (TCN-PM, VD-0002) in adults with metastatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) (triciribine phosphate monohydrate)

Snippet

Sponsor: Prescient Therapeutics, Ltd. | Conditions: Cancer | Phase 1 | Status: COMPLETED